CTMX: CytomX Therapeutics, Inc. Stock

by  •  • Comments Off on CTMX: CytomX Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 304.79
Enterprise Value ($M) 287.62
Book Value ($M) -47.45
Book Value / Share -0.70
Price / Book -6.42
NCAV ($M) -66.30
NCAV / Share -0.98
Price / NCAV -4.60

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.00
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.17
Current Ratio 1.17

Balance Sheet (mrq) ($M)
Current Assets 182.94
Assets 201.79
Liabilities 249.24
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 101.21
Operating Income -6.48
Net Income -0.57
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -56.03
Cash from Investing -150.67
Cash from Financing 30.23

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Tang Capital Partners Lp 9.80 86.59
02-14 13G/A Biotechnology Value Fund L P 9.99 1.62
02-13 13G/A Vanguard Group Inc 7.32 6.92

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 2,921,216 9,704,419 30.10
2024-05-02 3,906,936 13,699,923 28.52
2024-05-01 63,273,435 186,593,155 33.91
2024-04-30 44,921 97,457 46.09
2024-04-29 59,824 84,992 70.39

(click for more detail)

Similar Companies
CRBU – Caribou Biosciences, Inc. CRGX – CARGO Therapeutics, Inc.
CRNX – Crinetics Pharmaceuticals, Inc. CYTK – Cytokinetics, Incorporated
DAWN – Day One Biopharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io